Search research articles
Contact Us
Filters
Showing results (91-100 of 181) with videos related to
Page
of 19
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
May 12, 2018
Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials
Hossein Maymani, Kenneth Hess, Roman Groisberg, et al.
JCO Precision Oncology
|
September 11, 2020
Atypical, Non-V600 BRAF Mutations as a Potential Mechanism of Resistance to EGFR Inhibition in Metastatic Colorectal Cancer
Benny Johnson, Jonathan M Loree, Alexandre A Jacome, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
April 19, 2018
Evaluating for Pseudoprogression in Colorectal and Pancreatic Tumors Treated With Immunotherapy
Christine M Parseghian, Madhavi Patnana, Priya Bhosale, et al.
Annals of Surgical Oncology
|
March 25, 2025
ASO Visual Abstract: Improved Outcomes Following Resection of Perihilar Cholangiocarcinoma-A 27-Year Experience
Anish J Jain, Mateo Lendoire, Antony Haddad, et al.
Annals of Surgical Oncology
|
February 25, 2025
Improved Outcomes Following Resection of Perihilar Cholangiocarcinoma: A 27-Year Experience
Anish J Jain, Mateo Lendoire, Antony Haddad, et al.
Annals of Surgery
|
July 6, 2019
Radiographic and Serologic Predictors of Pathologic Major Response to Preoperative Therapy for Pancreatic Cancer
Giampaolo Perri, Laura Prakash, Huamin Wang, et al.
Investigational New Drugs
|
June 29, 2022
First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors
Todd Bauer, Byong Chul Cho, Rebecca Heist, et al.
Nature Medicine
|
August 12, 2025
Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results
Zev A Wainberg, Colin D Weekes, Muhammad Furqan, et al.
Cancer
|
March 7, 2023
A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF-10502-01 for the treatment of advanced solid tumors
Filip Janku, Milind M Javle, Shiraj Sen, et al.
JCO Precision Oncology
|
July 14, 2022
Longitudinal Monitoring of Circulating Tumor DNA to Predict Treatment Outcomes in Advanced Cancers
Mohamed A Gouda, Helen J Huang, Sarina A Piha-Paul, et al.
Page
of 19
Search research articles
Search
Showing results (91-100 of 181) with videos related to
Sort By:
Page
of 19
Lung Cancer (Amsterdam, Netherlands)
|
May 12, 2018
Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials
Hossein Maymani, Kenneth Hess, Roman Groisberg, et al.
JCO Precision Oncology
|
September 11, 2020
Atypical, Non-V600 BRAF Mutations as a Potential Mechanism of Resistance to EGFR Inhibition in Metastatic Colorectal Cancer
Benny Johnson, Jonathan M Loree, Alexandre A Jacome, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
April 19, 2018
Evaluating for Pseudoprogression in Colorectal and Pancreatic Tumors Treated With Immunotherapy
Christine M Parseghian, Madhavi Patnana, Priya Bhosale, et al.
Annals of Surgical Oncology
|
March 25, 2025
ASO Visual Abstract: Improved Outcomes Following Resection of Perihilar Cholangiocarcinoma-A 27-Year Experience
Anish J Jain, Mateo Lendoire, Antony Haddad, et al.
Annals of Surgical Oncology
|
February 25, 2025
Improved Outcomes Following Resection of Perihilar Cholangiocarcinoma: A 27-Year Experience
Anish J Jain, Mateo Lendoire, Antony Haddad, et al.
Annals of Surgery
|
July 6, 2019
Radiographic and Serologic Predictors of Pathologic Major Response to Preoperative Therapy for Pancreatic Cancer
Giampaolo Perri, Laura Prakash, Huamin Wang, et al.
Investigational New Drugs
|
June 29, 2022
First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors
Todd Bauer, Byong Chul Cho, Rebecca Heist, et al.
Nature Medicine
|
August 12, 2025
Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results
Zev A Wainberg, Colin D Weekes, Muhammad Furqan, et al.
Cancer
|
March 7, 2023
A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF-10502-01 for the treatment of advanced solid tumors
Filip Janku, Milind M Javle, Shiraj Sen, et al.
JCO Precision Oncology
|
July 14, 2022
Longitudinal Monitoring of Circulating Tumor DNA to Predict Treatment Outcomes in Advanced Cancers
Mohamed A Gouda, Helen J Huang, Sarina A Piha-Paul, et al.
Page
of 19